STOCK PHOTO/Adobe
A significant study released on Thursday reveals that mortality rates from cervical cancer are 49% greater for females residing in disadvantaged circumstances.
Furthermore, women experiencing poverty faced a 23% higher likelihood of contracting cervical cancer in comparison to those in more affluent regions, as indicated by the findings from the American Association of Cancer Research (AACR).
“The inequalities observed in this scenario stem from an issue related to accessing healthcare,” stated Dr. Paul DiSilvestro, who directs the division of gynecologic oncology at Women and Infants Hospital in Providence, Rhode Island, and was not associated with the research. He shared these thoughts with ABC News.
“I believe we frequently underestimate the pressures women face concerning screenings. Occasionally, individuals must choose between attending work, looking after their children, providing sustenance, and undergoing a screening test,” he elaborated.
Human papillomavirus (HPV), a virus, is the primary cause of cervical cancer. This illness is now largely preventable due to the advent of the HPV vaccine approximately two decades ago. Research indicates that the vaccine has substantially decreased fatality rates associated with cervical cancer.
When cervical cancer is detected in its early stages, treatment is generally more manageable, according to the National Cancer Institute. However, not all women have the opportunity to receive the vaccine during adolescence or undergo routine screenings as adults.
STOCK PHOTO/Adobe
Some public health professionals suggest that recent statistics indicate a reduction in pronounced racial disparities, although significant progress is still needed.
In the year 2000, Hispanic women were 70% more prone to succumbing to cervical cancer compared to white women, according to the AACR report. By 2024, the report found that Hispanic women were 10% more likely to die from cervical cancer.
Nationwide initiatives and strategies aimed at narrowing these disparity gaps have been implemented. The AACR reports a 62% increase in cervical screening following the integration of patient navigation services.
A study within the AACR summary compiled data from 20 trials conducted across the nation. This data included details on services such as aid with transportation, interpretation assistance, home visits, patient education, help with scheduling appointments, and individualized financial support.
It was discovered that community members from Hispanic/Latino backgrounds who received specialized training to deliver fundamental health education within their communities, referred to as promotoras, played crucial roles—alongside social workers, telephone counselors, and case managers—in providing these services.
Policy adjustments, such as the expansion of Medicaid, have also led to discernible improvements in screening rates among populations that were previously without insurance, the study indicates.
Despite these endeavors, individuals residing in less affluent counties continue to experience less favorable health outcomes, according to DiSilvestro.
“We must improve our approach to delivering screenings within the community rather than expecting the community to come to us for screenings,” he remarked.
The Centers for Disease Control (CDC) advises two doses of the HPV vaccine for individuals at ages 11 or 12, a vaccination that has demonstrated its ability to prevent up to 90% of cervical cancer cases.
The CDC also suggests commencing screening Pap smears at age 21. Pap smears are performed to detect cellular changes on the cervix that have the potential to develop into cervical cancer.
“I believe we cannot overlook the fact that cervical cancer screening is effective in this context,” DiSilvestro stated. “However, its effectiveness is contingent on our ability to make it accessible to people.”
Areta Bojko, MD, is a fellowship-trained gynecologic oncologist and a board-certified OBGYN at Women and Infants Hospital, as well as a member of the ABC News Medical Unit.
Sourse: abcnews.go.com